Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 02 May 2014 | By Louise Zornoza,
India's Central Drugs Standard Control Organization (CDSCO) has issued a call for comments on its new formula for determining compensation for patients injured in clinical trials.
According to the draft, Draft Formula to Determine the Quantum of Compensation in Case of Clinical Trial Related Injury (Other Than Death), in cases of Serious Adverse Events (SAE) other than death, the CDSCO will determine the cause of injury and decide the amount of compensation.
The regulator said it plans to take into consideration the reports of the clinical trial investigator, the trial sponsor and the Ethics Committee that approved the trial.
The deadline for submitting comments is 16 May 2014, after which the drafting committee convened by Shri R. K. Jain will prepare a final version drawing on the comments submitted.
Read all Breaking News from RegLink
Tags: Injury Compensation, clinical trial, clinical trials
Regulatory Focus newsletters
All the biggest regulatory news and happenings.